Form 4: H.B. Fuller Executive Campe Reports Acquisition of Phantom Units and Dividend Reinvestment
SEC Form 4 Filing
Heather Campe, Sr. VP of International Growth at H.B. Fuller, reports the acquisition of phantom units and shares through dividend reinvestment.
Summary
- Heather Campe, a Senior Vice President at H.B. Fuller, filed a Form 4 detailing changes in her beneficial ownership of the company's securities.
- The report indicates the acquisition of 25.51 phantom units on July 19, 2024, which convert into common stock on a 1-for-1 basis.
- Campe also acquired shares of common stock through a dividend reinvestment plan, increasing her direct holdings to 19,741.79 shares.
- The report also lists existing holdings of employee stock options and restricted stock units with varying vesting schedules and expiration dates.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions by an executive. The acquisition of phantom units and dividend reinvestment could be seen as a positive sign of confidence, but it's not a major event.
Positives
- The acquisition of phantom units and reinvestment of dividends indicate a continued investment and alignment with the company's performance.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Comparison to Industry Standards
- Comparing H.B. Fuller's executive compensation structure with peers like Avery Dennison or 3M would provide context on the prevalence of stock options and restricted stock units.
- Analyzing the vesting schedules and exercise prices of these equity grants relative to industry benchmarks can reveal whether H.B. Fuller's incentives are competitive.
- Reviewing similar Form 4 filings from executives at comparable companies can offer insights into typical insider trading patterns and ownership trends.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 01/25/2019 | Date of employee stock option grant (Right-to-Buy) at $53.57, expiring 01/25/2028. |
| 01/27/2022 | Date of employee stock option grant (Right-to-Buy) at $51.89, expiring 01/27/2031. |
| 01/24/2023 | Start date for vesting of 591.45 restricted stock units. |
| 01/24/2023 | Date of employee stock option grant (Right-to-Buy) at $72.94, expiring 01/24/2032. |
| 01/24/2024 | Start date for vesting of 1,207.55 restricted stock units. |
| 01/24/2024 | Date of employee stock option grant (Right-to-Buy) at $68.17, expiring 01/24/2033. |
| 01/26/2025 | Start date for vesting of 1,669.07 restricted stock units. |
| 07/19/2024 | Date of transaction: acquisition of phantom units. |
| 07/22/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.